Published Online
on June 28, 2004

A more recent version of this article appeared on August 1, 2004

This Article Full Text (PDF) All Versions of this Article: 44/2/123    most recent 01.HYP.0000136129.18326.26v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by White, W. B. Search for Related Content PubMed PubMed Citation Articles by White, W. B. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CELECOXIB Medline Plus Health Information High Blood Pressure Joint Disorders Osteoarthritis Related Collections Other hypertension

Hypertension Associated With Therapies to Treat Arthritis and Pain

William B. White^*

From the Division of Hypertension and Clinical Pharmacology, Center for Cardiology and Cardiovascular Biology, University of Connecticut School of Medicine, Farmington.

^* To whom correspondence should be addressed. E-mail: wwhite{at}nso1.uchc.edu.

This article has been cited by other articles:

				W. B. White Cardiovascular Effects of the Cyclooxygenase Inhibitors Hypertension, March 1, 2007; 49(3): 408 - 418. [Full Text] [PDF]

				F. H. Messerli Aspirin: A Novel Antihypertensive Drug?: Or Two Birds With One Stone? J. Am. Coll. Cardiol., September 20, 2005; 46(6): 984 - 985. [Full Text] [PDF]

				M. Hermann, S. Shaw, E. Kiss, G. Camici, N. Buhler, R. Chenevard, T. F. Luscher, H. J. Grone, and F. Ruschitzka Selective COX-2 Inhibitors and Renal Injury in Salt-Sensitive Hypertension Hypertension, February 1, 2005; 45(2): 193 - 197. [Abstract] [Full Text] [PDF]

				J. R. Sowers, W. B. White, B. Pitt, A. Whelton, L. S. Simon, N. Winer, A. Kivitz, H. van Ingen, T. Brabant, J. G. Fort, et al. The Effects of Cyclooxygenase-2 Inhibitors and Nonsteroidal Anti-inflammatory Therapy on 24-Hour Blood Pressure in Patients With Hypertension, Osteoarthritis, and Type 2 Diabetes Mellitus Arch Intern Med, January 24, 2005; 165(2): 161 - 168. [Abstract] [Full Text] [PDF]

				S. A. Grover, L. Coupal, and H. Zowall Treating Osteoarthritis With Cyclooxygenase-2-Specific Inhibitors: What Are the Benefits of Avoiding Blood Pressure Destabilization? Hypertension, January 1, 2005; 45(1): 92 - 97. [Abstract] [Full Text] [PDF]